Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4870255
Max Phase: Preclinical
Molecular Formula: C14H6O9
Molecular Weight: 318.19
Molecule Type: Unknown
Associated Items:
ID: ALA4870255
Max Phase: Preclinical
Molecular Formula: C14H6O9
Molecular Weight: 318.19
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O
Standard InChI: InChI=1S/C14H6O9/c15-8-9-4(2-6(11(16)17)13(20)22-9)1-5-3-7(12(18)19)14(21)23-10(5)8/h1-3,15H,(H,16,17)(H,18,19)
Standard InChI Key: ZZIRZFOBUDJXAR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 318.19 | Molecular Weight (Monoisotopic): 318.0012 | AlogP: 1.00 | #Rotatable Bonds: 2 |
Polar Surface Area: 155.25 | Molecular Species: ACID | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.02 | CX Basic pKa: | CX LogP: 1.11 | CX LogD: -5.93 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.46 | Np Likeness Score: 0.36 |
1. Wei L, Hou T, Li J, Zhang X, Zhou H, Wang Z, Cheng J, Xiang K, Wang J, Zhao Y, Liang X.. (2021) Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle., 64 (5.0): [PMID:33630609] [10.1021/acs.jmedchem.0c01624] |
Source(1):